Our findings position FCGR2A as a pivotal orchestrator of immune-metabolic crosstalk, bridging adipocyte-driven inflammation with tumor microenvironment remodeling through its dual roles in phagocytic signaling and Fcγ receptor-mediated myeloid activation (82). Here, FCGR2A is linked to neoplasm.